Bio Rad Laboratories Inc
NYSE:BIO
Bio Rad Laboratories Inc
Cash from Financing Activities
Bio Rad Laboratories Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bio Rad Laboratories Inc
NYSE:BIO
|
Cash from Financing Activities
-$425.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
-3%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Financing Activities
-$3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Danaher Corp
NYSE:DHR
|
Cash from Financing Activities
-$144m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Financing Activities
-$859.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-13%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Financing Activities
-$382m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is Bio Rad Laboratories Inc's Cash from Financing Activities?
Cash from Financing Activities
-425.6m
USD
Based on the financial report for Dec 31, 2023, Bio Rad Laboratories Inc's Cash from Financing Activities amounts to -425.6m USD.
What is Bio Rad Laboratories Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-3%
The average annual Cash from Financing Activities growth rates for Bio Rad Laboratories Inc have been 7% over the past three years , -54% over the past five years , and -3% over the past ten years .